MPs activate pro‐inflammatory pathways, such as NF‐κB and MAPK, which lead to increased production of cytokines, such as IL‐6 and TNF‐α—factors implicated in insulin resistance as well as carcinogenesis [18, 23, 36, 69]. This evidence concerns the gene NFKB1 and Insulin resistance.